source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[biological replicate]	characteristics[individual]	assay name	Technology Type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[technical replicate]	comment[label]	comment[instrument]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	factor value[disease]	factor value[organism part]
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 1	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 2	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 3	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 4	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 5	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 6	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 7	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 8	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 9	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 10	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 11	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-1	homo sapiens	Amygdala	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 12	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_A146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_A146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Amygdala
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 13	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 14	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 15	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 16	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 17	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 18	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 19	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 20	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 21	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 22	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 23	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-2	homo sapiens	Cerebellum	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 24	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_C146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_C146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Cerebellum
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 25	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 26	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 27	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 28	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 29	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 30	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 31	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 32	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 33	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 34	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 35	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-3	homo sapiens	Caudate Nucleus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 36	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_CN146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_CN146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Caudate Nucleus
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 37	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 38	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 39	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 40	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 41	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 42	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 43	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 44	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 45	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 46	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 47	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-4	homo sapiens	Entorhinal Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 48	proteomic profiling by mass spectrometry	PXD012131	20171002_JMM_EC146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171002_JMM_EC146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 49	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 50	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 51	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 52	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 53	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 54	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 55	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 56	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 57	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 58	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 59	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-5	homo sapiens	Inferior Parietal Lobule	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 60	proteomic profiling by mass spectrometry	PXD012131	20171017_JMM_IPL146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171017_JMM_IPL146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Inferior Parietal Lobule
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 61	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 62	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 63	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 64	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 65	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 66	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 67	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 68	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 69	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 70	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 71	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-6	homo sapiens	Middle Frontal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 72	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_MFG146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_MFG146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Middle Frontal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 73	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 74	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 75	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 76	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 77	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 78	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 79	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 80	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 81	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 82	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 83	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-7	homo sapiens	Superior Temporal Gyrus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 84	proteomic profiling by mass spectrometry	PXD012131	20171018_JMM_STG146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171018_JMM_STG146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Superior Temporal Gyrus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 85	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 86	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 87	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 88	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 89	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 90	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 91	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 92	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 93	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 94	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 95	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-8	homo sapiens	Thalamus	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 96	proteomic profiling by mass spectrometry	PXD012131	20171019_JMM_T146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171019_JMM_T146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Thalamus
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 97	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 98	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 99	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 100	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 101	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 102	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 103	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 104	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 105	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 106	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 107	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-9	homo sapiens	Visual Cortex	not applicable	80Y	not applicable	female	Normal	adult	1	146	run 108	proteomic profiling by mass spectrometry	PXD012131	20171025_JMM_VC146_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171025_JMM_VC146_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Visual Cortex
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 109	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 110	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 111	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 112	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 113	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 114	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 115	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 116	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 117	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 118	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 119	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-10	homo sapiens	Amygdala	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 120	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_A383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_A383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Amygdala
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 121	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 122	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 123	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 124	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 125	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 126	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 127	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 128	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 129	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 130	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 131	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-11	homo sapiens	Cerebellum	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 132	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_C383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_C383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Cerebellum
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 133	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 134	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 135	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 136	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 137	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 138	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 139	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 140	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 141	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 142	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 143	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-12	homo sapiens	Caudate Nucleus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 144	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_CN383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_CN383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Caudate Nucleus
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 145	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_1_20171030180857.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_1_20171030180857.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 146	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_2_20171030194117.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_2_20171030194117.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 147	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_3_20171030211337.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_3_20171030211337.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 148	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_4_20171030224557.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_4_20171030224557.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 149	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_5_20171031001818.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_5_20171031001818.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 150	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_6_20171031015038.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_6_20171031015038.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 151	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_7_20171031032258.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_7_20171031032258.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 152	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_8_20171031045518.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_8_20171031045518.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 153	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_9_20171031062739.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_9_20171031062739.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 154	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_10_20171031080000.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_10_20171031080000.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 155	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_11_20171031093221.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_11_20171031093221.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-13	homo sapiens	Entorhinal Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 156	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_EC383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_EC383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 157	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 158	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 159	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 160	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 161	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 162	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 163	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 164	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 165	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 166	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 167	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-14	homo sapiens	Inferior Parietal Lobule	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 168	proteomic profiling by mass spectrometry	PXD012131	20171026_JMM_IPL383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171026_JMM_IPL383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Inferior Parietal Lobule
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 169	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 170	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 171	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 172	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 173	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 174	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 175	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 176	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 177	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 178	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 179	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-15	homo sapiens	Middle Frontal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 180	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_MFG383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_MFG383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Middle Frontal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 181	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 182	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 183	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 184	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 185	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 186	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 187	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 188	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 189	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 190	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 191	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-16	homo sapiens	Superior Temporal Gyrus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 192	proteomic profiling by mass spectrometry	PXD012131	20171101_JMM_STG383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171101_JMM_STG383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Superior Temporal Gyrus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 193	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 194	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 195	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 196	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 197	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 198	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 199	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 200	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 201	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 202	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 203	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-17	homo sapiens	Thalamus	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 204	proteomic profiling by mass spectrometry	PXD012131	20171102_JMM_T383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171102_JMM_T383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Thalamus
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 205	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 206	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 207	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 208	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 209	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 210	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 211	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 212	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 213	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 214	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 215	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-18	homo sapiens	Visual Cortex	not applicable	79Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	383	run 216	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_VC383_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_VC383_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Visual Cortex
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 217	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 218	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 219	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 220	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 221	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 222	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 223	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 224	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 225	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 226	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 227	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-19	homo sapiens	Amygdala	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 228	proteomic profiling by mass spectrometry	PXD012131	20171103_JMM_A405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171103_JMM_A405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Amygdala
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 229	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 230	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 231	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 232	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 233	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 234	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 235	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 236	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 237	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 238	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_CN405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_CN405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 239	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-20	homo sapiens	Caudate Nucleus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 240	proteomic profiling by mass spectrometry	PXD012131	20171113_JMM_CN405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171113_JMM_CN405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Caudate Nucleus
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 241	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 242	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 243	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 244	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 245	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 246	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 247	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 248	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 249	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 250	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 251	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-21	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 252	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_EC405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_EC405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Entorhinal Cortex
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 253	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 254	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 255	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 256	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 257	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 258	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 259	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 260	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 261	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 262	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 263	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-22	homo sapiens	Inferior Parietal Lobule	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 264	proteomic profiling by mass spectrometry	PXD012131	20171114_JMM_IPL405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171114_JMM_IPL405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Inferior Parietal Lobule
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 265	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 266	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 267	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 268	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 269	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 270	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 271	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 272	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 273	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 274	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 275	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-23	homo sapiens	Middle Frontal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 276	proteomic profiling by mass spectrometry	PXD012131	20171115_JMM_MFG405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171115_JMM_MFG405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Middle Frontal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 277	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 278	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 279	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 280	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 281	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 282	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 283	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 284	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 285	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 286	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 287	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-24	homo sapiens	Superior Temporal Gyrus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 288	proteomic profiling by mass spectrometry	PXD012131	20171116_JMM_STG405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171116_JMM_STG405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Superior Temporal Gyrus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 289	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 290	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 291	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 292	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 293	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 294	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 295	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 296	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 297	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 298	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 299	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-25	homo sapiens	Thalamus	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 300	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_T405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_T405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Thalamus
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 301	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_1.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_1.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 302	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_2.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_2.raw	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 303	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_3.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_3.raw	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 304	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_4.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_4.raw	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 305	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_5.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_5.raw	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 306	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_6.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_6.raw	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 307	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_7.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_7.raw	7	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 308	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_8.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_8.raw	8	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 309	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_9.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_9.raw	9	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 310	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_10.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_10.raw	10	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 311	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_11.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_11.raw	11	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-26	homo sapiens	Visual Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage III)	adult	1	405	run 312	proteomic profiling by mass spectrometry	PXD012131	20171117_JMM_VC405_12.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20171117_JMM_VC405_12.raw	12	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage III)	Visual Cortex
PXD012131-Sample-27	homo sapiens	Entorhinal Cortex	not applicable	85Y	not applicable	female	Normal	adult	1	199	run 313	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_199E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_199E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-28	homo sapiens	Neocortex	not applicable	85Y	not applicable	female	Normal	adult	1	199	run 314	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_199N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_199N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Neocortex
PXD012131-Sample-29	homo sapiens	Entorhinal Cortex	not applicable	86Y	not applicable	female	Normal	adult	1	254	run 315	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_254E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_254E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-30	homo sapiens	Neocortex	not applicable	86Y	not applicable	female	Normal	adult	1	254	run 316	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_254N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_254N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Neocortex
PXD012131-Sample-31	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	343	run 317	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_343E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_343E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-32	homo sapiens	Neocortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	343	run 318	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_343N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_343N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Neocortex
PXD012131-Sample-33	homo sapiens	Entorhinal Cortex	not applicable	84Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	372	run 319	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_372E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_372E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-34	homo sapiens	Neocortex	not applicable	84Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	372	run 320	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_372N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_372N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Neocortex
PXD012131-Sample-35	homo sapiens	Entorhinal Cortex	not applicable	81Y	not applicable	male	Normal	adult	1	384	run 321	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_384E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_384E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Entorhinal Cortex
PXD012131-Sample-36	homo sapiens	Neocortex	not applicable	81Y	not applicable	male	Normal	adult	1	384	run 322	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_384N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_384N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Normal	Neocortex
PXD012131-Sample-37	homo sapiens	Entorhinal Cortex	not applicable	74Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	403	run 323	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_403E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_403E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-38	homo sapiens	Neocortex	not applicable	74Y	not applicable	male	Alzheimer's disease (stage VI)	adult	1	403	run 324	proteomic profiling by mass spectrometry	PXD012131	20181130_JMM_403N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181130_JMM_403N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Neocortex
PXD012131-Sample-39	homo sapiens	Entorhinal Cortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	440	run 325	proteomic profiling by mass spectrometry	PXD012131	20181202_JMM_440E.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181202_JMM_440E.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Entorhinal Cortex
PXD012131-Sample-40	homo sapiens	Neocortex	not applicable	78Y	not applicable	female	Alzheimer's disease (stage VI)	adult	1	440	run 326	proteomic profiling by mass spectrometry	PXD012131	20181201_JMM_440N.raw	ftp://ftp.ebi.ac.uk/pride-archive/2020/01/20181201_JMM_440N.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1002732;NT=Orbitrap Fusion Lumos	20 ppm	0.5 Da	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-Term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	Alzheimer's disease (stage VI)	Neocortex
